STUDY REVEALS SOCIOECONOMIC BARRIERS TO CHILDREN’S HEALTHCARE ACCESS. NSW, WA and SA commence reforms allowing GPs to diagnosis and treat ADHD
With
Dr Anita Muñoz, General Practitioner &
Royal Australian College of GPs (RACGP) Victoria Chair
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne | August 2025
Research published in the Australian Journal of General Practice (AJGP) has revealed mental health and developmental–behavioural issues such as ADHD are the most common paediatric referrals in metropolitan general practices.
But the research also revealed children at higher risk are less likely to get the care they may need.
The study of 49,932 consultations at 22 GP clinics in Victoria and New South Wales found private billing specialist GPs were around 1.7 times more likely to refer than bulk billing GPs in the sample – and most referrals were to private billing paediatric specialists.
Corresponding author, consultant paediatrician, and University of Melbourne Professor Harriet Hiscock said the study showed a clear difference in children’s access to appropriate care depending on their socioeconomic status.
She said the study showed the need for greater investment in primary care and public paediatric mental health services, as well as for integrated care between GPs and paediatricians.
“Children from lower socioeconomic areas are more likely to have mental health and developmental–behavioural problems than those from wealthier areas,” Professor Hiscock said.
“However, these children were more likely to attend bulk billing practices and received fewer referrals for specialist care.
“We need more investment in public specialist paediatric services and paediatric mental health services.
“We also need more investment in paediatric primary care, including properly funding longer GP-patient consults, funding co-consults between GPs and paediatric specialists, and empowering GPs to diagnose and treat developmental concerns such as ADHD, especially in lower socioeconomic areas.”
The governments of New South Wales, Western Australia and South Australia, have announced they will allow GPs to work to their full scope of practice to diagnose and treat ADHD. Children in Queensland have been able to access ADHD diagnosis and support for eight years.
GPs in Victoria, Tasmania and the Australian Capital Territory have also called for GPs to be able to diagnose ADHD to improve access to treatment. In Victoria, a shared care ADHD pilot is underway with GPs and paediatricians.
Australian Health Journal spoke with Royal Australian College of GPs (RACGP) Victoria Chair Dr Anita Muñoz about the study and the reform underway.
Source: Adapted from RACGP Media Release
-
Landmark research projects tackle critical issues in emergency healthcare
For two decades, the demand for emergency department services in Australia has outpaced population growth and wait times have increased. In 2022-2023 more than 8.8 million emergency department presentations occurred nationwide.
While demand is a contributing factor, EDs are currently being impacted by various factors across the entire health system.
The Emergency Medicine Foundation (EMF) is a non-profit organisation funding innovative Australian research that improves the way people are cared for in a medical emergency. The aim of the research is to deliver better and more effective health services to save lives and money.
-
New treatment options under investigation for pelvic organ prolapse
Dr Shayanti Mukherjee, Research Group Head, Translational Tissue Engineering at the with her team at Hudson Institute of Medical Research is developing new ways to prevent and potential cure pelvic organ prolapse (POP). The technology aims to ultimately lead to safer and more effective treatment for women with pelvic organ prolapse (POP) using a woman’s own stem cells to boost the effectiveness of a degradable mesh.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
